Drug Type Small molecule drug |
Synonyms MK 5720, MK5720 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Schizophrenia | Phase 1 | United States | 15 Sep 2023 |
Phase 1 | 17 | (Panel A: Period 1 MK-8189 4 mg) | lsqphuspho = okrhbxipcz wzxiyrvqqi (wqbntbbfrf, mnadxzwtua - fraiivrcet) View more | - | 04 Mar 2025 | ||
(Panel B: Period 1 MK-8189 8 mg) | lsqphuspho = ujfoekdnwc wzxiyrvqqi (wqbntbbfrf, iaslasfdbj - psnrxiyvuz) View more |





